| 1 | Kidney Neoplasm | 43.8% |
| 2 | Ureteral Neoplasms | 43.8% |
| 3 | Urethral Neoplasms | 43.8% |
| 4 | Bladder neck obstruction | 34.4% |
| 5 | Bladder Exstrophy | 32.5% |
| 6 | Cystitis | 31.8% |
| 7 | Vesico-Ureteral Reflux | 31.8% |
| 8 | Mesoblastic Nephroma | 30.5% |
| 9 | Renal Cell Carcinoma | 29.9% |
| 10 | Papillary Renal Cell Carcinoma | 29.9% |
| 11 | Urinary Bladder Fistula | 28.8% |
| 12 | Cystocele | 27.8% |
| 13 | Nephroblastoma | 27.3% |
| 14 | Pyelocystitis | 26.4% |
| 15 | Anuria | 26.2% |
| 16 | Ureterolithiasis | 26.2% |
| 17 | Nephrolithiasis | 26.2% |
| 18 | Kidney Diseases | 25.6% |
| 19 | Ureteral Diseases | 25.6% |
| 20 | Urethral Diseases | 25.6% |
| 21 | Urination Disorders | 25.6% |
| 22 | Urolithiasis | 25.6% |
| 23 | Genital Neoplasms, Female | 23.9% |
| 24 | Genital Neoplasms, Male | 23.8% |
| 25 | Urinary tract infection | 22.6% |
| 26 | Epispadias | 21.9% |
| 27 | Kidney Calculi | 21.8% |
| 28 | Ureteral Calculi | 21.8% |
| 29 | Tuberculosis, Renal | 21.7% |
| 30 | Urogenital Abnormalities | 21.5% |
| 31 | Denys-Drash Syndrome | 19.6% |
| 32 | Multicystic Dysplastic Kidney | 18.8% |
| 33 | Uterine Neoplasms | 18.7% |
| 34 | Vaginal Neoplasms | 18.7% |
| 35 | Vulvar Neoplasms | 18.7% |
| 36 | Uterine Cancer | 18.7% |
| 37 | Fallopian Tube Neoplasms | 17.4% |
| 38 | Hydronephrosis | 16.8% |
| 39 | Hyperoxaluria | 16.8% |
| 40 | Kidney Cortex Necrosis | 16.8% |
| 41 | Kidney Papillary Necrosis | 16.8% |
| 42 | Nephritis | 16.8% |
| 43 | Nephrosclerosis | 16.8% |
| 44 | Nephrosis | 16.8% |
| 45 | Perinephritis | 16.8% |
| 46 | Kidney Failure | 16.8% |
| 47 | Uremia | 16.8% |
| 48 | Ureteral obstruction | 16.8% |
| 49 | Ureterocele | 16.8% |
| 50 | Urethral Obstruction | 16.8% |
| 51 | Urethritis | 16.8% |
| 52 | Urinary Retention | 16.8% |
| 53 | Oxalosis | 16.8% |
| 54 | Renal Insufficiency | 16.8% |
| 55 | Penile Neoplasms | 16.8% |
| 56 | Prostatic Neoplasms | 16.8% |
| 57 | Pyelonephritis | 16.1% |
| 58 | Diabetes Insipidus | 14.9% |
| 59 | Hepatorenal Syndrome | 14.9% |
| 60 | Bacteriuria | 14.8% |
| 61 | Diabetic Nephropathy | 14.8% |
| 62 | Glycosuria | 14.8% |
| 63 | Hematuria | 14.8% |
| 64 | Renal hypertension | 14.8% |
| 65 | Oliguria | 14.8% |
| 66 | Polyuria | 14.8% |
| 67 | Proteinuria | 14.8% |
| 68 | Pyuria | 14.8% |
| 69 | Renal Artery Obstruction | 14.8% |
| 70 | Renal Artery Stenosis | 14.8% |
| 71 | Urinary Calculi | 14.8% |
| 72 | Nephrocalcinosis | 14.7% |
| 73 | Urinary Incontinence | 14.7% |
| 74 | Glycosuria, Renal | 14.6% |
| 75 | Vesicovaginal Fistula | 14.5% |
| 76 | Infertility | 14.2% |
| 77 | Testicular Neoplasms | 14.2% |
| 78 | Hypospadias | 14% |
| 79 | Endometrial Neoplasms | 13.9% |
| 80 | Enuresis | 13.2% |
| 81 | Carcinoma, Endometrioid | 13.2% |
| 82 | Glomerulonephritis | 12.5% |
| 83 | Nephritis, Interstitial | 12.5% |
| 84 | Lipoid nephrosis | 12.5% |
| 85 | Nephrotic Syndrome | 12.5% |
| 86 | Pyelitis | 12.5% |
| 87 | Pyonephrosis | 12.5% |
| 88 | Urethral Stenosis | 12.5% |
| 89 | Nephrogenic Diabetes Insipidus | 12.5% |
| 90 | Congenital Nephrogenic Diabetes Insipidus | 12.5% |
| 91 | Acute kidney injury | 12.5% |
| 92 | Urethral stricture | 12.5% |
| 93 | ovarian neoplasm | 12.5% |
| 94 | Horseshoe Kidney | 12.4% |
| 95 | Prostatic Neoplasms, Castration-Resistant | 12.4% |
| 96 | Urologic Diseases | 12.2% |
| 97 | AIDS-Associated Nephropathy | 11.7% |
| 98 | Sexually Transmitted Diseases | 11.4% |
| 99 | Genital Diseases, Male | 11.3% |
| 100 | Hermaphroditism | 11.2% |
| 101 | Disorders of Sex Development | 11.2% |
| 102 | Azotemia | 11.1% |
| 103 | Genital Herpes | 11% |
| 104 | Albuminuria | 11% |
| 105 | Hemoglobinuria | 11% |
| 106 | Hypertension, Renovascular | 11% |
| 107 | Urge Incontinence | 10.9% |
| 108 | Balkan Nephropathy | 10.4% |
| 109 | Focal glomerulosclerosis | 10.4% |
| 110 | Kidney Failure, Chronic | 10.4% |
| 111 | Pregnancy Complications | 10.2% |
| 112 | Endometriosis | 9.8% |
| 113 | Uterine Diseases | 9.8% |
| 114 | Vaginal Diseases | 9.8% |
| 115 | Vulvar Diseases | 9.8% |
| 116 | Endometrioma | 9.8% |
| 117 | Polycystic Kidney Diseases | 9.8% |
| 118 | Diurnal Enuresis | 9.8% |
| 119 | Endometritis | 9.7% |
| 120 | Renal Osteodystrophy | 9.7% |
| 121 | Renal rickets | 9.7% |
| 122 | Renal Aminoacidurias | 9.7% |
| 123 | Fanconi Syndrome | 9.7% |
| 124 | Pseudohypoaldosteronism | 9.7% |
| 125 | Liddle Syndrome | 9.7% |
| 126 | Hemolytic-Uremic Syndrome | 9.7% |
| 127 | Glomerulonephritis, Membranoproliferative | 9.4% |
| 128 | Pregnancy Complications, Neoplastic | 9.3% |
| 129 | granulosa cell tumor | 9% |
| 130 | Carcinoma, Ovarian Epithelial | 9% |
| 131 | Renal tubular acidosis | 8.8% |
| 132 | Uterine Inversion | 8.4% |
| 133 | Salpingitis | 8.3% |
| 134 | Vulvovaginitis | 8.3% |
| 135 | Abdominal Neoplasms | 8.3% |
| 136 | Head and Neck Neoplasms | 8.3% |
| 137 | Soft Tissue Neoplasms | 8.3% |
| 138 | Thoracic Neoplasms | 8.3% |
| 139 | Dyspareunia | 8.3% |
| 140 | Anti-Glomerular Basement Membrane Disease | 8.2% |
| 141 | Lupus Nephritis | 8.1% |
| 142 | Polycystic Kidney, Autosomal Dominant | 8.1% |
| 143 | Endometrial Stromal Sarcoma | 8.1% |
| 144 | Cystinuria | 8.1% |
| 145 | Atypical Hemolytic Uremic Syndrome | 8.1% |
| 146 | Leydig Cell Tumor | 8% |
| 147 | Zellweger Syndrome | 7.9% |
| 148 | Hyperandrogenism | 7.4% |
| 149 | Uterine Rupture | 7.4% |
| 150 | Cryptorchidism | 7.4% |
| 151 | Digestive System Neoplasms | 7.3% |
| 152 | Endocrine Gland Neoplasms | 7.3% |
| 153 | Eye Neoplasms | 7.3% |
| 154 | Nervous System Neoplasms | 7.3% |
| 155 | Oophoritis | 7.3% |
| 156 | Hyperphosphaturia | 7.3% |
| 157 | Gonadal Dysgenesis | 7.3% |
| 158 | Adrenogenital Syndrome | 7.3% |
| 159 | Ovotesticular Disorders of Sex Development | 7.3% |
| 160 | Bone neoplasms | 7.2% |
| 161 | Skin Neoplasms | 7.2% |
| 162 | Hematologic Neoplasms | 7.2% |
| 163 | Urinary Bladder Diseases | 7.1% |
| 164 | Splenic Neoplasms | 7.1% |
| 165 | Parathyroid Neoplasms | 6.7% |
| 166 | Peritoneal Neoplasms | 6.7% |
| 167 | Thyroid Neoplasm | 6.7% |
| 168 | Thyroid carcinoma | 6.7% |
| 169 | Epididymitis | 6.6% |
| 170 | Penile Diseases | 6.6% |
| 171 | Prostatic Diseases | 6.6% |
| 172 | Spermatic Cord Torsion | 6.6% |
| 173 | Hemospermia | 6.6% |
| 174 | Testicular Hydrocele | 6.6% |
| 175 | Bladder Neoplasm | 6.5% |
| 176 | Endometrial Hyperplasia | 6.5% |
| 177 | Pyometra | 6.5% |
| 178 | Vaginitis | 6.5% |
| 179 | Vulvitis | 6.5% |
| 180 | Vaginal Discharge | 6.5% |
| 181 | Vulvodynia | 6.5% |
| 182 | Multiple Endocrine Neoplasia | 6.4% |
| 183 | Urologic Neoplasms | 6.2% |
| 184 | Candidiasis, Vulvovaginal | 6.1% |
| 185 | Pancreatic Neoplasm | 6.1% |
| 186 | Uterine Cervical Incompetence | 6% |
| 187 | Chorioamnionitis | 5.9% |
| 188 | Paraneoplastic Encephalomyelitis | 5.9% |
| 189 | Trophoblastic Neoplasms | 5.8% |
| 190 | Mammary Neoplasms, Experimental | 5.8% |
| 191 | Corpus Luteum Cyst | 5.8% |
| 192 | Ovarian Cysts | 5.8% |
| 193 | Testicular Diseases | 5.7% |
| 194 | Varicocele | 5.7% |
| 195 | Spermatocele | 5.7% |
| 196 | Ovarian Diseases | 5.7% |
| 197 | Abruptio Placentae | 5.6% |
| 198 | Placenta Accreta | 5.6% |
| 199 | Adnexitis | 5.6% |
| 200 | Pruritus Vulvae | 5.6% |
| 201 | Uterine hemorrhage | 5.6% |
| 202 | Vaginal Fistula | 5.6% |
| 203 | Pelvic Inflammatory Disease | 5.6% |
| 204 | Uterine Prolapse | 5.6% |
| 205 | Vaginal Prolapse | 5.6% |
| 206 | Tracheal Neoplasms | 5.6% |
| 207 | Polyhydramnios | 5.5% |
| 208 | Obstetric Labor Complications | 5.5% |
| 209 | Ectopic Pregnancy | 5.5% |
| 210 | Pregnancy, Prolonged | 5.5% |
| 211 | Puerperal Disorders | 5.5% |
| 212 | Oligohydramnios | 5.5% |
| 213 | Prenatal Injuries | 5.5% |
| 214 | Turner Syndrome | 5.4% |
| 215 | Acanthoma | 5.1% |
| 216 | Hamartoma | 5.1% |
| 217 | Neoplasms, Hormone-Dependent | 5.1% |
| 218 | Neoplasms, Multiple Primary | 5.1% |
| 219 | Paraneoplastic Syndromes | 5.1% |
| 220 | Precancerous Conditions | 5.1% |
| 221 | Neoplasms, Second Primary | 5.1% |
| 222 | Puerperal Infection | 4.9% |
| 223 | Esophageal Neoplasms | 4.9% |
| 224 | Postpartum Hemorrhage | 4.9% |
| 225 | Retroperitoneal Neoplasms | 4.9% |
| 226 | Uterine Cervicitis | 4.9% |
| 227 | Chlamydia Infections | 4.9% |
| 228 | Fetal Diseases | 4.9% |
| 229 | Gonorrhea | 4.9% |
| 230 | Leukorrhea | 4.9% |
| 231 | Parametritis | 4.9% |
| 232 | Pregnancy Complications, Cardiovascular | 4.9% |
| 233 | Pregnancy Complications, Hematologic | 4.8% |
| 234 | Pregnancy Complications, Infectious | 4.8% |
| 235 | Fetal Death | 4.7% |
| 236 | Perinatal death | 4.7% |
| 237 | Morning Sickness | 4.7% |
| 238 | Carcinoma, Lobular | 4.5% |
| 239 | Kallmann Syndrome | 4.5% |
| 240 | Syphilis | 4.4% |
| 241 | Cyst | 4.4% |
| 242 | Neoplastic Processes | 4.4% |
| 243 | Neoplastic Syndromes, Hereditary | 4.4% |
| 244 | Balanitis | 4.4% |
| 245 | Benign prostatic hypertrophy | 4.4% |
| 246 | Phimosis | 4.4% |
| 247 | Priapism | 4.4% |
| 248 | prostatitis | 4.4% |
| 249 | Prostatic Adenoma | 4.4% |
| 250 | Benign Prostatic Hyperplasia | 4.4% |
| 251 | Prostatic Hypertrophy | 4.4% |
| 252 | Prostatic Hyperplasia | 4.4% |
| 253 | Thyroid Nodule | 4.4% |
| 254 | Neoplasms, Experimental | 4.3% |
| 255 | Polycystic Ovary Syndrome | 4.3% |
| 256 | Mouth Neoplasms | 4.3% |
| 257 | Central Nervous System Neoplasms | 4.3% |
| 258 | Vascular Neoplasms | 4.3% |
| 259 | Thymus Neoplasms | 4.3% |
| 260 | Bacterial Vaginosis | 4.2% |
| 261 | Familial Hypophosphatemic Rickets | 4.2% |
| 262 | Breast Neoplasms, Male | 4.2% |
| 263 | Triple Negative Breast Neoplasms | 4.2% |
| 264 | Trichomonas Vaginitis | 4.2% |
| 265 | Uterine Perforation | 4.2% |
| 266 | Ovarian Hyperstimulation Syndrome | 4.2% |
| 267 | Metrorrhagia | 4.2% |
| 268 | Gestational Diabetes | 4.2% |
| 269 | Klinefelter Syndrome | 4% |
| 270 | Lymphogranuloma Venereum | 4% |
| 271 | Carcinoma, Pancreatic Ductal | 4% |
| 272 | Multiple Endocrine Neoplasia Type 1 | 3.9% |
| 273 | Neoplasms, Radiation-Induced | 3.8% |
| 274 | Meningioma | 3.8% |
| 275 | Choriocarcinoma | 3.8% |
| 276 | Premature Ejaculation | 3.8% |
| 277 | Erectile dysfunction | 3.8% |
| 278 | Adrenal Gland Neoplasms | 3.8% |
| 279 | Gastrointestinal Neoplasms | 3.8% |
| 280 | Liver neoplasms | 3.8% |
| 281 | Uveal Neoplasms | 3.8% |
| 282 | Orchitis | 3.8% |
| 283 | Sebaceous Gland Neoplasms | 3.7% |
| 284 | Spinal Neoplasms | 3.7% |
| 285 | Bone Marrow Neoplasms | 3.7% |
| 286 | Thymoma | 3.7% |
| 287 | Anovulation | 3.7% |
| 288 | Menorrhagia | 3.7% |
| 289 | Premature Menopause | 3.6% |
| 290 | Liver Neoplasms, Experimental | 3.6% |
| 291 | Tuberous Sclerosis | 3.6% |
| 292 | Carcinoma 256, Walker | 3.5% |
| 293 | Nose Neoplasms | 3.4% |
| 294 | Acoustic Neuroma | 3.3% |
| 295 | Leukemia, Experimental | 3.3% |
| 296 | Carcinoma, Ehrlich Tumor | 3.3% |
| 297 | Dermoid Cyst | 3.3% |
| 298 | Carcinoma, Lewis Lung | 3.3% |
| 299 | Leukoplakia, Oral | 3.3% |
| 300 | Abortion, Habitual | 3.3% |
| 301 | Dystocia | 3.3% |
| 302 | Eclampsia | 3.3% |
| 303 | Fetal Membranes, Premature Rupture | 3.3% |
| 304 | Placental Insufficiency | 3.3% |
| 305 | Pre-Eclampsia | 3.3% |
| 306 | Prenatal Exposure Delayed Effects | 3.3% |
| 307 | HELLP Syndrome | 3.3% |
| 308 | Placenta, Retained | 3.3% |
| 309 | Paraneoplastic Cerebellar Degeneration | 3.3% |
| 310 | Azoospermia | 3.3% |
| 311 | Oligospermia | 3.3% |
| 312 | Impotence, Vasculogenic | 3.3% |
| 313 | Asthenozoospermia | 3.3% |
| 314 | Teratozoospermia | 3.3% |
| 315 | Aspermia | 3.3% |
| 316 | Palatal Neoplasms | 3.1% |
| 317 | Pituitary Adenoma | 3.1% |
| 318 | Pituitary Neoplasms | 3.1% |
| 319 | Melanoma, Experimental | 3.1% |
| 320 | Vipoma | 3.1% |
| 321 | insulinoma | 3.1% |
| 322 | Gastrinoma | 3% |
| 323 | Glucagonoma | 3% |
| 324 | Retinoblastoma | 3% |
| 325 | Leukemia, Radiation-Induced | 3% |
| 326 | Limbic Encephalitis | 2.9% |
| 327 | Hepatocellular Adenoma | 2.9% |
| 328 | Abortion, Veterinary | 2.9% |
| 329 | Pregnancy Complications, Parasitic | 2.9% |
| 330 | Sarcoma, Experimental | 2.9% |
| 331 | Neoplasms, Neuroepithelial | 2.9% |
| 332 | Gliomatosis cerebri | 2.9% |
| 333 | Lactation Disorder | 2.8% |
| 334 | Mastitis | 2.8% |
| 335 | Neuroectodermal Tumors | 2.8% |
| 336 | Depression, Postpartum | 2.8% |
| 337 | Embryo Loss | 2.8% |
| 338 | Fetal Resorption | 2.8% |
| 339 | Meningeal Neoplasms | 2.8% |
| 340 | Hyperemesis Gravidarum | 2.8% |
| 341 | Erythroplasia | 2.8% |
| 342 | Follicular cyst | 2.8% |
| 343 | leukemia | 2.8% |
| 344 | Mucocele | 2.8% |
| 345 | Neoplasms, Germ Cell and Embryonal | 2.8% |
| 346 | Neoplasms, Glandular and Epithelial | 2.8% |
| 347 | Pilonidal Cyst | 2.8% |
| 348 | Thyroglossal Cyst | 2.8% |
| 349 | Synovial Cyst | 2.8% |
| 350 | Germ Cell Cancer | 2.8% |
| 351 | Aberrant Crypt Foci | 2.8% |
| 352 | Lambert-Eaton Myasthenic Syndrome | 2.7% |
| 353 | Hydatidiform Mole | 2.6% |
| 354 | Optic Nerve Glioma | 2.6% |
| 355 | Prolactinoma | 2.6% |
| 356 | Growth Hormone-Secreting Pituitary Adenoma | 2.6% |
| 357 | Ear Neoplasms | 2.5% |
| 358 | Eyelid Neoplasms | 2.5% |
| 359 | Lung Neoplasms | 2.5% |
| 360 | Pleural Neoplasms | 2.5% |
| 361 | Fetal Growth Retardation | 2.5% |
| 362 | Embolism, Amniotic Fluid | 2.5% |
| 363 | Fetal Hypoxia | 2.5% |
| 364 | Opsoclonus-Myoclonus Syndrome | 2.5% |
| 365 | Fetal Alcohol Spectrum Disorders | 2.5% |
| 366 | Brain Neoplasms | 2.5% |
| 367 | Salivary Gland Neoplasms | 2.5% |
| 368 | Spinal Cord Neoplasms | 2.5% |
| 369 | Tongue Neoplasms | 2.5% |
| 370 | Breech Presentation | 2.5% |
| 371 | Stillbirth | 2.4% |
| 372 | melanoma | 2.4% |
| 373 | Leukoplakia | 2.4% |
| 374 | Lymphocele | 2.4% |
| 375 | Pancreatic Cyst | 2.4% |
| 376 | Adenomatous Polyposis Coli | 2.4% |
| 377 | Barrett Esophagus | 2.4% |
| 378 | Breast Cyst | 2.4% |
| 379 | Histiocytic Disorders, Malignant | 2.4% |
| 380 | Actinic keratosis | 2.4% |
| 381 | Mediastinal Cyst | 2.4% |
| 382 | Neoplasm Invasiveness | 2.4% |
| 383 | Neoplasm Metastasis | 2.4% |
| 384 | Neoplasm Recurrence, Local | 2.4% |
| 385 | Parovarian Cyst | 2.4% |
| 386 | Pericardial Cyst | 2.4% |
| 387 | Thymic Cyst | 2.4% |
| 388 | Carcinogenesis | 2.4% |
| 389 | Myxoid cyst | 2.4% |
| 390 | Metastasis | 2.4% |
| 391 | Lymphomatoid Granulomatosis | 2.4% |
| 392 | Carcinosarcoma | 2.3% |
| 393 | Hemangiosarcoma | 2.3% |
| 394 | Leukemia L1210 | 2.3% |
| 395 | Leukemia P388 | 2.3% |
| 396 | lymphangiosarcoma | 2.3% |
| 397 | Medulloblastoma | 2.3% |
| 398 | Myelitis, Transverse | 2.3% |
| 399 | Pharyngeal Neoplasms | 2.2% |
| 400 | Basal Cell Nevus Syndrome | 2.2% |
| 401 | Central Nervous System Cysts | 2.2% |
| 402 | Bile Duct Neoplasms | 2.2% |
| 403 | gallbladder neoplasm | 2.2% |
| 404 | Intestinal Neoplasms | 2.2% |
| 405 | Stomach Neoplasms | 2.2% |
| 406 | Composite Lymphoma | 2.2% |
| 407 | Premature Birth | 2.2% |
| 408 | Polycythemia Vera | 2.2% |
| 409 | Sarcoma 180 | 2.1% |
| 410 | Meningeal Carcinomatosis | 2.1% |
| 411 | Lymphoma | 2.1% |
| 412 | Leukemia, Plasma Cell | 2% |
| 413 | Laryngeal neoplasm | 2% |
| 414 | Adenoma, Acidophil | 2% |
| 415 | Ganglioneuroma | 2% |
| 416 | Glioma | 2% |
| 417 | Malignant Glioma | 2% |
| 418 | Meconium Aspiration Syndrome | 2% |
| 419 | Adrenocortical carcinoma | 1.9% |
| 420 | Basal cell carcinoma | 1.9% |
| 421 | Carcinoma, Papillary | 1.9% |
| 422 | Squamous cell carcinoma | 1.9% |
| 423 | Chondrosarcoma | 1.9% |
| 424 | Craniopharyngioma | 1.9% |
| 425 | Cystadenoma | 1.9% |
| 426 | leiomyosarcoma | 1.9% |
| 427 | liposarcoma | 1.9% |
| 428 | Mesothelioma | 1.9% |
| 429 | synovial sarcoma | 1.9% |
| 430 | Neuroectodermal Tumor, Melanotic | 1.9% |
| 431 | Angiomyolipoma | 1.9% |
| 432 | Clear Cell Sarcoma of Soft Tissue | 1.9% |
| 433 | Alveolar Soft Part Sarcoma | 1.9% |
| 434 | Neuroendocrine Tumors | 1.9% |
| 435 | Galactorrhea | 1.9% |
| 436 | Sarcoma, Myeloid | 1.9% |
| 437 | Carcinoma, Basal Cell | 1.9% |
| 438 | Choledochal Cyst | 1.9% |
| 439 | Bronchial Neoplasms | 1.9% |
| 440 | Multiple Pulmonary Nodules | 1.8% |
| 441 | Peutz-Jeghers Syndrome | 1.8% |
| 442 | Supratentorial Neoplasms | 1.8% |
| 443 | Carcinoid Tumor | 1.8% |
| 444 | Neurilemmoma | 1.8% |
| 445 | Hutchinson's Melanotic Freckle | 1.8% |
| 446 | Melanoma, Amelanotic | 1.8% |
| 447 | Adenoma | 1.6% |
| 448 | Ameloblastoma | 1.6% |
| 449 | Angiokeratoma | 1.6% |
| 450 | Carcinoma | 1.6% |
| 451 | Chordoma | 1.6% |
| 452 | Hemangioma | 1.6% |
| 453 | hemangiopericytoma | 1.6% |
| 454 | Hypopharyngeal Neoplasms | 1.6% |
| 455 | Lymphangioma | 1.6% |
| 456 | Mesenchymoma | 1.6% |
| 457 | Nevus | 1.6% |
| 458 | Teratoma | 1.6% |
| 459 | Pleural Effusion, Malignant | 1.6% |
| 460 | Hypopharyngeal Cancer | 1.6% |
| 461 | Hepatoblastoma | 1.6% |
| 462 | Mixed Tumor, Mullerian | 1.6% |
| 463 | Germinoma | 1.6% |
| 464 | Teratocarcinoma | 1.6% |
| 465 | Angiofibroma | 1.6% |
| 466 | Sarcoma | 1.6% |
| 467 | Epithelioma | 1.6% |
| 468 | Cystadenocarcinoma | 1.6% |
| 469 | Fibrosarcoma | 1.6% |
| 470 | Osteosarcoma | 1.6% |
| 471 | Mucoepidermoid Carcinoma | 1.6% |
| 472 | Parotid Neoplasms | 1.6% |
| 473 | Nelson Syndrome | 1.6% |
| 474 | Astrocytoma | 1.6% |
| 475 | Ependymoma | 1.6% |
| 476 | oligodendroglioma | 1.6% |
| 477 | Ganglioglioma | 1.6% |
| 478 | gliosarcoma | 1.6% |
| 479 | Anaplastic astrocytoma | 1.6% |
| 480 | Anaplastic Oligodendroglioma | 1.6% |
| 481 | Nasopharyngeal carcinoma | 1.6% |
| 482 | Brain Stem Neoplasms | 1.5% |
| 483 | Malignant Carcinoid Syndrome | 1.5% |
| 484 | Adenofibroma | 1.5% |
| 485 | Fibroadenoma | 1.5% |
| 486 | Malignant Fibrous Histiocytoma | 1.5% |
| 487 | Cecal Neoplasms | 1.5% |
| 488 | Duodenal Neoplasms | 1.5% |
| 489 | Lymphangioleiomyomatosis | 1.4% |
| 490 | Glioblastoma | 1.4% |
| 491 | Neuroblastoma | 1.4% |
| 492 | Pancreatic Pseudocyst | 1.4% |
| 493 | Plasmacytoma | 1.4% |
| 494 | Glioblastoma Multiforme | 1.4% |
| 495 | Malignant histiocytosis | 1.4% |
| 496 | Lymphatic Metastasis | 1.4% |
| 497 | Neoplasms, Unknown Primary | 1.4% |
| 498 | Leukemic Infiltration | 1.4% |
| 499 | Histiocytic sarcoma | 1.4% |
| 500 | Neoplasm Micrometastasis | 1.4% |
| 501 | Bowen's Disease | 1.4% |
| 502 | Paraganglioma | 1.4% |
| 503 | Rhabdomyosarcoma | 1.4% |
| 504 | Giant Cell Tumor of Bone | 1.4% |
| 505 | Neurofibrosarcoma | 1.4% |
| 506 | Choroid Plexus Papilloma | 1.4% |
| 507 | Tonsillar Neoplasms | 1.4% |
| 508 | Cerebellar Neoplasms | 1.3% |
| 509 | Nasopharyngeal Neoplasms | 1.3% |
| 510 | Colorectal Neoplasms | 1.3% |
| 511 | Ganglioneuroblastoma | 1.3% |
| 512 | Xeroderma Pigmentosum | 1.3% |
| 513 | Dermatofibrosarcoma | 1.3% |
| 514 | Dermatofibrosarcoma Protuberans | 1.3% |
| 515 | Paranasal Sinus Neoplasms | 1.2% |
| 516 | Hodgkin Disease | 1.2% |
| 517 | Lymphoma, Non-Hodgkin | 1.2% |
| 518 | Carcinoid Heart Disease | 1.2% |
| 519 | Appendiceal Neoplasms | 1.2% |
| 520 | Colonic Neoplasms | 1.2% |
| 521 | Rectal Neoplasms | 1.2% |
| 522 | Pheochromocytoma | 1.2% |
| 523 | Alveolar rhabdomyosarcoma | 1.2% |
| 524 | Hydrops Fetalis | 1.1% |
| 525 | Primary amyloidosis | 1.1% |
| 526 | Adenocarcinoma | 1.1% |
| 527 | Carcinoma in Situ | 1.1% |
| 528 | Carcinoma, Transitional Cell | 1.1% |
| 529 | Phyllodes Tumor | 1.1% |
| 530 | Dysgerminoma | 1.1% |
| 531 | Hemangioendothelioma | 1.1% |
| 532 | Lipoma | 1.1% |
| 533 | Myoma | 1.1% |
| 534 | Myxoma | 1.1% |
| 535 | Neuroma | 1.1% |
| 536 | Papilloma | 1.1% |
| 537 | Pseudomyxoma Peritonei | 1.1% |
| 538 | Seminoma | 1.1% |
| 539 | Papillomatosis | 1.1% |
| 540 | Angiolipoma | 1.1% |
| 541 | Myelolipoma | 1.1% |
| 542 | Neoplasms, Bone Tissue | 1.1% |
| 543 | Neoplasms, Fibrous Tissue | 1.1% |
| 544 | Smooth Muscle Tumor | 1.1% |
| 545 | Adenomatosis, Pulmonary | 1.1% |
| 546 | Adenomatous Polyps | 1.1% |
| 547 | Carcinoma, Large Cell | 1.1% |
| 548 | Carcinoma, Small Cell | 1.1% |
| 549 | Desmoplastic Small Round Cell Tumor | 1.1% |
| 550 | Chondroma | 1.1% |
| 551 | Enchondroma | 1.1% |
| 552 | Maxillary Sinus Neoplasms | 1% |
| 553 | Anus Neoplasms | 1% |
| 554 | Sigmoid Neoplasms | 1% |
| 555 | Leukemia, Myelomonocytic, Chronic | 0.9% |
| 556 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.9% |
| 557 | Waldenstrom Macroglobulinemia | 0.9% |
| 558 | Multiple Myeloma | 0.9% |
| 559 | Mastocytosis | 0.8% |
| 560 | Sturge-Weber Syndrome | 0.8% |
| 561 | Cell Transformation, Viral | 0.8% |
| 562 | Zollinger-Ellison syndrome | 0.8% |
| 563 | Gastrointestinal Stromal Tumors | 0.8% |
| 564 | Hemangioma, Cavernous | 0.8% |
| 565 | Adenoid Cystic Carcinoma | 0.8% |
| 566 | fibroma | 0.8% |
| 567 | Fibromatosis | 0.8% |
| 568 | Leukemia, T-Cell | 0.8% |
| 569 | Osteoblastoma | 0.8% |
| 570 | Osteoma | 0.8% |
| 571 | Rhabdomyoma | 0.8% |
| 572 | Chondromatosis | 0.8% |
| 573 | Adenocarcinoma, Clear Cell | 0.8% |
| 574 | Cholangiocarcinoma | 0.8% |
| 575 | Cervical Intraepithelial Neoplasia | 0.8% |
| 576 | Hemangioblastoma | 0.8% |
| 577 | Lymphoma, Extranodal NK-T-Cell | 0.8% |
| 578 | Leukemia, B-Cell | 0.8% |
| 579 | neurofibroma | 0.8% |
| 580 | Lymphoma, Follicular | 0.8% |
| 581 | T-Cell Lymphoma | 0.8% |
| 582 | Mantle cell lymphoma | 0.8% |
| 583 | Mastocytoma | 0.7% |
| 584 | Mastocytosis, Systemic | 0.7% |
| 585 | Leukemia, Myeloid, Chronic-Phase | 0.7% |
| 586 | Fibromatosis, Aggressive | 0.7% |
| 587 | Fibromatosis, Abdominal | 0.7% |
| 588 | Klatskin Tumor | 0.7% |
| 589 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.6% |
| 590 | Leukemia, Large Granular Lymphocytic | 0.6% |
| 591 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.6% |
| 592 | Lymphoma, T-Cell, Cutaneous | 0.6% |
| 593 | Lymphoma, AIDS-Related | 0.6% |
| 594 | Enteropathy-Associated T-Cell Lymphoma | 0.6% |
| 595 | Primary Effusion Lymphoma | 0.6% |
| 596 | Dupuytren Contracture | 0.5% |
| 597 | Urticaria Pigmentosa | 0.5% |
| 598 | Mycosis Fungoides | 0.5% |
| 599 | Lymphomatoid Papulosis | 0.5% |
| 600 | Plasmablastic lymphoma | 0.5% |
| 601 | Burkitt Lymphoma | 0.5% |
| 602 | Sezary Syndrome | 0.4% |
| 603 | Radicular Cyst | 0.4% |
